Psychoimmunoendocrine aspects of panic disorder

F. Brambilla, L. Bellodi, G. Perna, M. Battaglia, G. Sciuto, G. Diaferia, F. Petraglia, A. Panerai, P. Sacerdote

Research output: Contribution to journalArticle

Abstract

Immunological, neuroendocrine and psychological parameters were examined in 14 psychophvsically healthy subjects and in 17 panic disorder patients before and after a 30-day course of alprazolam therapy. T lymphocyte proliferation in response to the mitogen phytohemoagglutinin, lymphocyte beta- endorphin (β-EP) concentrations, plasma ACTH. cortisol and β -EP levels were examined in basal conditions and after corticotropin-releasing hormone (CRH) stimulation. Cortisol inhibition by dexamethasone (DST) and basal growth hormone (GH) and prolactin levels were also examined. Depression, state or trait anxiety, anticipatory anxiety, agoraphobia, simple and social phobias, severity and frequency of panic attacks were monitored by rating scales. The immune study did not reveal any significant difference between patients and controls, or any effect of alprazolam therapy. The hormonal data for the two groups were similar, except for higher than normal basal ACTH and GH plasma levels, lower than normal ratios between the ACTH and cortisol responses to CRH. and blunted DST in some patients. All the impairments improved after alprazolam therapy, in parallel with decreases in anxiety and in severity and frequency of panic attacks.

Original languageEnglish
Pages (from-to)12-22
Number of pages11
JournalNeuropsychobiology
Volume26
Issue number1-2
DOIs
Publication statusPublished - 1992

Fingerprint

Alprazolam
Panic Disorder
Adrenocorticotropic Hormone
Hydrocortisone
Anxiety
Corticotropin-Releasing Hormone
Growth Hormone
Agoraphobia
beta-Endorphin
Mitogens
Prolactin
Dexamethasone
Healthy Volunteers
Therapeutics
Lymphocytes
Depression
Psychology
T-Lymphocytes

Keywords

  • ACTH Cortisol
  • Corticotropin-releasing hormone test
  • Dexamethasone inhibition test
  • Growth hormone
  • Panic disorder
  • PH A test
  • Prolactin
  • β-Endorphin

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)
  • Psychology(all)

Cite this

Brambilla, F., Bellodi, L., Perna, G., Battaglia, M., Sciuto, G., Diaferia, G., ... Sacerdote, P. (1992). Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology, 26(1-2), 12-22. https://doi.org/10.1159/000118890

Psychoimmunoendocrine aspects of panic disorder. / Brambilla, F.; Bellodi, L.; Perna, G.; Battaglia, M.; Sciuto, G.; Diaferia, G.; Petraglia, F.; Panerai, A.; Sacerdote, P.

In: Neuropsychobiology, Vol. 26, No. 1-2, 1992, p. 12-22.

Research output: Contribution to journalArticle

Brambilla, F, Bellodi, L, Perna, G, Battaglia, M, Sciuto, G, Diaferia, G, Petraglia, F, Panerai, A & Sacerdote, P 1992, 'Psychoimmunoendocrine aspects of panic disorder', Neuropsychobiology, vol. 26, no. 1-2, pp. 12-22. https://doi.org/10.1159/000118890
Brambilla F, Bellodi L, Perna G, Battaglia M, Sciuto G, Diaferia G et al. Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology. 1992;26(1-2):12-22. https://doi.org/10.1159/000118890
Brambilla, F. ; Bellodi, L. ; Perna, G. ; Battaglia, M. ; Sciuto, G. ; Diaferia, G. ; Petraglia, F. ; Panerai, A. ; Sacerdote, P. / Psychoimmunoendocrine aspects of panic disorder. In: Neuropsychobiology. 1992 ; Vol. 26, No. 1-2. pp. 12-22.
@article{eb267480901243cd90e54b13fac1bca9,
title = "Psychoimmunoendocrine aspects of panic disorder",
abstract = "Immunological, neuroendocrine and psychological parameters were examined in 14 psychophvsically healthy subjects and in 17 panic disorder patients before and after a 30-day course of alprazolam therapy. T lymphocyte proliferation in response to the mitogen phytohemoagglutinin, lymphocyte beta- endorphin (β-EP) concentrations, plasma ACTH. cortisol and β -EP levels were examined in basal conditions and after corticotropin-releasing hormone (CRH) stimulation. Cortisol inhibition by dexamethasone (DST) and basal growth hormone (GH) and prolactin levels were also examined. Depression, state or trait anxiety, anticipatory anxiety, agoraphobia, simple and social phobias, severity and frequency of panic attacks were monitored by rating scales. The immune study did not reveal any significant difference between patients and controls, or any effect of alprazolam therapy. The hormonal data for the two groups were similar, except for higher than normal basal ACTH and GH plasma levels, lower than normal ratios between the ACTH and cortisol responses to CRH. and blunted DST in some patients. All the impairments improved after alprazolam therapy, in parallel with decreases in anxiety and in severity and frequency of panic attacks.",
keywords = "ACTH Cortisol, Corticotropin-releasing hormone test, Dexamethasone inhibition test, Growth hormone, Panic disorder, PH A test, Prolactin, β-Endorphin",
author = "F. Brambilla and L. Bellodi and G. Perna and M. Battaglia and G. Sciuto and G. Diaferia and F. Petraglia and A. Panerai and P. Sacerdote",
year = "1992",
doi = "10.1159/000118890",
language = "English",
volume = "26",
pages = "12--22",
journal = "Neuropsychobiology",
issn = "0302-282X",
publisher = "S. Karger AG",
number = "1-2",

}

TY - JOUR

T1 - Psychoimmunoendocrine aspects of panic disorder

AU - Brambilla, F.

AU - Bellodi, L.

AU - Perna, G.

AU - Battaglia, M.

AU - Sciuto, G.

AU - Diaferia, G.

AU - Petraglia, F.

AU - Panerai, A.

AU - Sacerdote, P.

PY - 1992

Y1 - 1992

N2 - Immunological, neuroendocrine and psychological parameters were examined in 14 psychophvsically healthy subjects and in 17 panic disorder patients before and after a 30-day course of alprazolam therapy. T lymphocyte proliferation in response to the mitogen phytohemoagglutinin, lymphocyte beta- endorphin (β-EP) concentrations, plasma ACTH. cortisol and β -EP levels were examined in basal conditions and after corticotropin-releasing hormone (CRH) stimulation. Cortisol inhibition by dexamethasone (DST) and basal growth hormone (GH) and prolactin levels were also examined. Depression, state or trait anxiety, anticipatory anxiety, agoraphobia, simple and social phobias, severity and frequency of panic attacks were monitored by rating scales. The immune study did not reveal any significant difference between patients and controls, or any effect of alprazolam therapy. The hormonal data for the two groups were similar, except for higher than normal basal ACTH and GH plasma levels, lower than normal ratios between the ACTH and cortisol responses to CRH. and blunted DST in some patients. All the impairments improved after alprazolam therapy, in parallel with decreases in anxiety and in severity and frequency of panic attacks.

AB - Immunological, neuroendocrine and psychological parameters were examined in 14 psychophvsically healthy subjects and in 17 panic disorder patients before and after a 30-day course of alprazolam therapy. T lymphocyte proliferation in response to the mitogen phytohemoagglutinin, lymphocyte beta- endorphin (β-EP) concentrations, plasma ACTH. cortisol and β -EP levels were examined in basal conditions and after corticotropin-releasing hormone (CRH) stimulation. Cortisol inhibition by dexamethasone (DST) and basal growth hormone (GH) and prolactin levels were also examined. Depression, state or trait anxiety, anticipatory anxiety, agoraphobia, simple and social phobias, severity and frequency of panic attacks were monitored by rating scales. The immune study did not reveal any significant difference between patients and controls, or any effect of alprazolam therapy. The hormonal data for the two groups were similar, except for higher than normal basal ACTH and GH plasma levels, lower than normal ratios between the ACTH and cortisol responses to CRH. and blunted DST in some patients. All the impairments improved after alprazolam therapy, in parallel with decreases in anxiety and in severity and frequency of panic attacks.

KW - ACTH Cortisol

KW - Corticotropin-releasing hormone test

KW - Dexamethasone inhibition test

KW - Growth hormone

KW - Panic disorder

KW - PH A test

KW - Prolactin

KW - β-Endorphin

UR - http://www.scopus.com/inward/record.url?scp=0026566934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026566934&partnerID=8YFLogxK

U2 - 10.1159/000118890

DO - 10.1159/000118890

M3 - Article

C2 - 1335559

AN - SCOPUS:0026566934

VL - 26

SP - 12

EP - 22

JO - Neuropsychobiology

JF - Neuropsychobiology

SN - 0302-282X

IS - 1-2

ER -